In addition, EpCAM positivity was confirmed in our series of samples showing strong immunostaining in well-differentiated tumour areas while positivity was moderate in poorly differentiated tumour areas (Supplementary Figure S3). This evidence concerns the gene EPCAM and neoplasm.